This Human Monoclonal antibody specifically detects CEACAM5 (Cergutuzumab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.
Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb)
Characteristics
Anti-CEACAM5 / CEA / CD66e Reference Antibody (cergutuzumAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG1
Application Notes
Optimal working dilution should be determined by the investigator.